China Tech Digest: SenseTime Delays Hong Kong IPO; Pony.ai Voluntarily Suspends Autonomous Driving Testing In California


SenseTime delays Hong Kong IPO

Chinese artificial intelligence company SenseTime announced that its global offering and Hong Kong IPO will be delayed. According to people familiar with the matter, SenseTime will continue to firmly promote the Hong Kong IPO, which will be completed by the end of this year at the earliest.

Cambricon provides infrastructure support for an intelligent computing center

Chinese AI chip developer Cambricon announced that it has signed a procurement contract for the infrastructure construction project of an Intelligent Computing Center with Jiangsu Kunshan High-tech Industry Investment Development Co., Ltd. The contract value is about RMB509 million.

Pony.ai voluntarily suspends autonomous driving testing in California

Chinese autonomous driving firm Pony.ai is no longer in the list of fully autonomous driving test licenses on the official website of California DMV. Prior to this, Pony.ai’s unmanned vehicle test encountered a minor collision in California, and no one was injured, and no other vehicles were involved. After the accident, Pony.ai immediately conducted a review of the incident and stopped the autonomous driving testing in California. At the same time, Pony.ai immediately reported to the California DMV and is still in close communication.

Shenzhen’s first industrial Internet innovation center launched

Shenzhen’s first industrial Internet innovation center-Huawei (Longgang) Industrial Internet Innovation Center was launched a few days ago. The center has been in operation for a year and has provided 258 industrial companies with digital transformation solutions, developed 24 local ecological partners, and built more than 10 digital transformation benchmarks.

China first self-developed fully magnetic-levitation artificial heart debuts

A few days ago, the 2nd Critical Heart Disease Conference hosted by Shenzhen Hospital of Fuwai Hospital, Chinese Academy of Medical Sciences, was held in Shenzhen. Suzhou CH Biomedical’s innovative product-implantable left ventricular assist device "CH-VAD" (artificial heart) has been approved for marketing. It is China’s first self-developed fully magnetic-levitation artificial heart.

(China Money Network’s articles are curated and translated from credible Chinese media organizations with established brands, experienced editorial teams, and trustworthy journalism practices. However, we are not responsible for the accuracy of the information. For any questions, please reach out to our editorial department.)

China Money Network Subscription
 
Caishen.Co - Primary Data for China Secondary Investment and Stock Markets
Introducing Finley, the fintech newsbot from China Money Network! Using state-of-the-art machine learning technologies, Finley scours the globe for immediately usable data about the latest private equity deals, venture capital funding rounds, and business expansions happening in China. Finley asks: Who's buying whom? What company just raised new capital? What is the relationship among the parties? Then Finley uses his very real artificial intelligence to decipher that unstructured data to write news articles for you to read. So from unstructured data to a news story you can understand, China Money Network's Finley is your fintech newsbot business partner!

RELATED NEWS



LEAVE A REPLY